A key factor to successful secondary prevention of cardiovascular disease (CVD) is optimal patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for CVD risk factors and CVD have been observed consistently over the last few decades. Hence, achieving optimal adherence to lifestyle measures and guideline-directed medical therapy in secondary prevention and rehabilitation is a great challenge to many healthcare professionals. Therefore, in this European Association of Preventive Cardiology clinical consensus document, a modern reappraisal of the adherence to optimal treatment is provided, together with simple, practical, and feasible suggestions to achieve this goal in the clinical setting, focusing on evidence-based concepts.

Pedretti, R., Hansen, D., Ambrosetti, M., Back, M., Berger, T., Ferreira, M., et al. (2023). How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 30(2), 149-166 [10.1093/eurjpc/zwac204].

How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology

Pedretti R. F. E.
Primo
;
Steca P.;
2023

Abstract

A key factor to successful secondary prevention of cardiovascular disease (CVD) is optimal patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for CVD risk factors and CVD have been observed consistently over the last few decades. Hence, achieving optimal adherence to lifestyle measures and guideline-directed medical therapy in secondary prevention and rehabilitation is a great challenge to many healthcare professionals. Therefore, in this European Association of Preventive Cardiology clinical consensus document, a modern reappraisal of the adherence to optimal treatment is provided, together with simple, practical, and feasible suggestions to achieve this goal in the clinical setting, focusing on evidence-based concepts.
Articolo in rivista - Articolo scientifico
Adherence; Cardiovascular disease; Cardiovascular risk; Secondary prevention;
English
13-set-2022
2023
30
2
149
166
partially_open
Pedretti, R., Hansen, D., Ambrosetti, M., Back, M., Berger, T., Ferreira, M., et al. (2023). How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 30(2), 149-166 [10.1093/eurjpc/zwac204].
File in questo prodotto:
File Dimensione Formato  
Pedretti-2023-Eur J Prev Cardiol-AAM.pdf

accesso aperto

Tipologia di allegato: Author’s Accepted Manuscript, AAM (Post-print)
Licenza: Altro
Dimensione 2.04 MB
Formato Adobe PDF
2.04 MB Adobe PDF Visualizza/Apri
zwac204.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 739.29 kB
Formato Adobe PDF
739.29 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/525617
Citazioni
  • Scopus 75
  • ???jsp.display-item.citation.isi??? 76
Social impact